Jack L Wyszomierski sold $4.4M of EXEL
director at EXELIXIS, INC.. 99,574 shares at an average of $44.01, traded Feb 18, 2026, filed Feb 20, 2026.
Score components
- +15RoleDirector
- +25Trade size$4.4M at market
- +10Share of holdings soldSold 26% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.4%, 3m +14.9%, 6m +24.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000939767-26-000030, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | MOption exercise Common Stock10b5-1 | +20,634 | $19.77 | $408k | 379,516 | Feb 20, 2026 |
| Feb 18, 2026 | SOpen-market sale Common Stock10b5-1 | -99,574 | $44.01 | $4.4M | 279,942 | Feb 20, 2026 |
| Feb 18, 2026 | MOption exercise Option (right to buy)derivative10b5-1 | -20,634 | $0.00 | $0 | 0 | Feb 20, 2026 |
Related signals
Other insiders at EXELIXIS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | EXELIXIS, INC. | Mary C Beckerle director | $527k 9,812 shares | -38% | |
| 38Weak | EXELIXIS, INC. | Sue Gail Eckhardt director | $492k 9,812 shares | -38% | |
| 22Weak | EXELIXIS, INC. | Jack L Wyszomierski director | $198k 3,925 shares | -1% | |
| 55Moderate | EXELIXIS, INC. | Dana Aftab EVP, Research and Development | $2.2M 43,451 shares | -7% | |
| 55Moderate | EXELIXIS, INC. | Patrick J. Haley EVP, Commercial | $1.6M 32,110 shares | -8% | |
| 25Weak | EXELIXIS, INC. | Brenda Hefti SVP and General Counsel | $333k 6,625 shares | -6% | |
| 62Notable | EXELIXIS, INC. | Christopher J. Senner EVP and CFO | $1.7M 34,901 shares | -4% | |
| 40Moderate | EXELIXIS, INC. | Mary C Beckerle director | $374k 7,712 shares | -31% | |
| 65Notable | EXELIXIS, INC. | George Poste director | $2.7M 60,000 shares | -34% | |
| 44Moderate | EXELIXIS, INC. | Maria C Freire director | $949k 20,634 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.